Biotricity Return on Tangible Equity 2015-2024 | BTCY
Current and historical return on tangible equity values for Biotricity (BTCY) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Biotricity Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-06-30 | $-0.02B | $-0.03B | 62.07% |
| 2024-03-31 | $-0.02B | $-0.03B | 55.05% |
| 2023-12-31 | $-0.02B | $-0.03B | 65.31% |
| 2023-09-30 | $-0.02B | $-0.03B | 84.71% |
| 2023-06-30 | $-0.02B | $-0.02B | 110.14% |
| 2023-03-31 | $-0.02B | $-0.02B | 150.94% |
| 2022-12-31 | $-0.02B | $-0.02B | 240.00% |
| 2022-09-30 | $-0.02B | $-0.01B | 511.11% |
| 2022-06-30 | $-0.03B | $-0.01B | -11600.00% |
| 2022-03-31 | $-0.03B | $-0.00B | 4000.00% |
| 2021-12-31 | $-0.03B | $0.00B | 1500.00% |
| 2021-09-30 | $-0.03B | $0.01B | 514.29% |
| 2021-06-30 | $-0.02B | $-0.01B | 211.11% |
| 2021-03-31 | $-0.02B | $-0.01B | 213.33% |
| 2020-12-31 | $-0.02B | $-0.01B | 230.77% |
| 2020-09-30 | $-0.01B | $-0.01B | 305.88% |
| 2020-06-30 | $-0.01B | $-0.01B | 320.00% |
| 2020-03-31 | $-0.01B | $-0.00B | 440.00% |
| 2019-12-31 | $-0.01B | $-0.00B | 355.56% |
| 2019-09-30 | $-0.01B | $-0.01B | 457.14% |
| 2019-06-30 | $-0.01B | 1600.00% | |
| 2019-03-31 | $-0.01B | $-0.00B | 1600.00% |
| 2018-12-31 | $-0.01B | inf% | |
| 2018-09-30 | $-0.01B | inf% | |
| 2018-06-30 | $-0.01B | inf% | |
| 2018-03-31 | $-0.01B | $0.00B | inf% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.012B |
| Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $5.733B | 148.28 |
| Inspire Medical Systems (INSP) | United States | $5.716B | 178.27 |
| Axonics (AXNX) | United States | $3.603B | 1762.25 |
| IRhythm Technologies (IRTC) | United States | $2.729B | 0.00 |
| Privia Health (PRVA) | United States | $2.710B | 225.80 |
| Enovis (ENOV) | United States | $2.621B | 17.77 |
| Omnicell (OMCL) | United States | $2.264B | 74.08 |
| Azenta (AZTA) | United States | $2.250B | 112.17 |
| 10x Genomics (TXG) | United States | $1.898B | 0.00 |
| Schrodinger (SDGR) | United States | $1.620B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.617B | 0.00 |
| Phreesia (PHR) | United States | $1.235B | 0.00 |
| Standard BioTools (LAB) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.569B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.528B | 91.40 |
| Health Catalyst (HCAT) | United States | $0.495B | 0.00 |
| Pulmonx (LUNG) | United States | $0.278B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.261B | 0.00 |
| TruBridge (TBRG) | United States | $0.234B | 67.96 |
| P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.056B | 0.00 |
| CareCloud (CCLD) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | China | $0.049B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.017B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |